VOYA Investment Management
VIR icon

VOYA Investment Management’s Vir Biotechnology VIR Stock Holding History

VOYA Investment Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$146K Sell
16,325
-470
-3% -$3.75K ﹤0.01% 2155
2025
Q4 		$101K Hold
16,795
– – ﹤0.01% 2258
2025
Q3 		$95.9K Sell
16,795
-8,004
-32% -$40.9K ﹤0.01% 2310
2025
Q2 		$125K Buy
24,799
+363
+1% +$1.95K ﹤0.01% 2436
2025
Q1 		$158K Sell
24,436
-2,879
-11% -$25.6K ﹤0.01% 2330
2024
Q4 		$200K Sell
27,315
-2,382
-8% -$18.8K ﹤0.01% 2393
2024
Q3 		$222K Sell
29,697
-357
-1% -$3.1K ﹤0.01% 2426
2024
Q2 		$267K Buy
30,054
+2,225
+8% +$21.3K ﹤0.01% 2312
2024
Q1 		$282K Sell
27,829
-6,143
-18% -$62.6K ﹤0.01% 2280
2023
Q4 		$342K Buy
33,972
+440
+1% +$4.02K ﹤0.01% 2274
2023
Q3 		$314K Buy
33,532
+536
+2% +$7.64K ﹤0.01% 2282
2023
Q2 		$809K Sell
32,996
-2,542
-7% -$63.8K ﹤0.01% 1801
2023
Q1 		$827K Sell
35,538
-2,200
-6% -$56.3K ﹤0.01% 1768
2022
Q4 		$955K Sell
37,738
-4,544
-11% -$111K ﹤0.01% 1660
2022
Q3 		$815K Sell
42,282
-3,933
-9% -$100K ﹤0.01% 1737
2022
Q2 		$1.18M Buy
46,215
+22,496
+95% +$525K ﹤0.01% 1321
2022
Q1 		$610K Buy
23,719
+597
+3% +$17.7K ﹤0.01% 1788
2021
Q4 		$968K Sell
23,122
-271
-1% -$10.6K ﹤0.01% 1569
2021
Q3 		$1.02M Sell
23,393
-341
-1% -$14.8K ﹤0.01% 1558
2021
Q2 		$1.12M Buy
23,734
+265
+1% +$12K ﹤0.01% 1561
2021
Q1 		$1.2M Buy
23,469
+163
+0.7% +$8.79K ﹤0.01% 1470
2020
Q4 		$624K Buy
23,306
+5,158
+28% +$168K ﹤0.01% 1775
2020
Q3 		$623K Buy
18,148
+2,130
+13% +$91.7K ﹤0.01% 1533
2020
Q2 		$656K Buy
+16,018
New +$538K ﹤0.01% 1480

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

VOYA Investment Management's VIR Position: Q1 2026 in Review

VOYA Investment Management reduced its Vir Biotechnology (VIR) stake by 2.8% in Q1 2026, selling an estimated $3.75K and leaving 16,325 shares worth $146K. The position accounts for ﹤0.01% of the portfolio, ranked #2155.

VOYA Investment Management first reported a position in VIR in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.2M in Q1 2021. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • VOYA Investment Management held 16,325 shares of Vir Biotechnology worth $146K as of Q1 2026.
  • VOYA Investment Management sold 470 Vir Biotechnology shares in Q1 2026, an estimated $3.75K.
  • Vir Biotechnology made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2155 holding.
  • VOYA Investment Management first reported a position in Vir Biotechnology in Q2 2020 and has held it in 24 quarters since.
  • VOYA Investment Management's Vir Biotechnology position peaked at $1.2M in Q1 2021.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.